Delivery Order SPE2DB24D3013-SPE2DB25FFQLF
- Not listed
- The Defense Logistics Agency awarded a $3,666.64 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This is a firm fixed price, non-set-aside contract with a completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a prescription medication used to treat osteoporosis and increase bone density, and this order represents a...
- On June 10, 2025, the Defense Logistics Agency awarded a delivery order valued at $12,258.03 to AmerisourceBergen Drug Corp for Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This firm fixed-price, non-set-aside delivery order is scheduled for completion by June 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a prescription medication used to treat osteoporosis and increase bone mass, representing a specialized...
- The Defense Logistics Agency awarded a $22,105.54 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This contract represents a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was utilized for this competitive award. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $1,833.32 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is not set-aside and was competitively awarded, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) valued at $14,661.05. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.32 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 ml pen injections) on September 7, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Forteo is a prescription medication used to treat osteoporosis and increase bone mass in patients at risk...
- The Defense Logistics Agency awarded a $13,965.22 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The contract will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 1, 2025. This non-set-aside contract represents a single delivery order fulfillment of this pharmaceutical product, which is commonly used for osteoporosis treatment. The award was made to AmerisourceBergen's Corporate Office division, based in Conshohocken, Pennsylvania, where the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injection) valued at $4,239.43 with a firm fixed price structure. This is a non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQLFDelivery Order
The Defense Logistics Agency awarded a $2,749.98 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used to treat osteoporosis and bone-related conditions, and this award reflects the ongoing pharmaceutical supply needs of federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated consistent capability to fulfill federal requirements through competitive awards across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/10/25 |